Exhibit 31.1
 
 Rule 13a-14(a)/15d-14(a)
Certification
  I, Liu Zhong Yi, certify
that:
 
 1.    I have
reviewed this annual report
on Form 10-K for the year ended December 31, 2008 of Lotus Pharmaceuticals,
Inc.;
 
 2.    Based on my
knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make thestatements made, in light of the
circumstancesunder which
such statements weremade,
not misleading with respect to the period covered by this
report;
 
 3.    Based on my
knowledge, the financial statements, and other financial information included in
this report, fairly present
in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
report;
 
 4.    The
registrant’s other certifying officer(s) and I are
responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant andhave:
 
 a.    Designed such
disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated
subsidiaries,is made known
to us by others within those entities, particularly during the period in which
this report is being prepared;
 
 b.    Designed such
internal control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
 
 c.    Evaluated
theeffectiveness of the
registrant's disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such
evaluation; and
 
 d.    Disclosed in
this report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of
an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial
reporting; and
 
 5.    The
registrant's other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internalcontrol over financial reporting, to the
registrant's auditors and the audit committee of the registrant’s board of directors (or persons
performing the equivalent functions):
 
 a.    All
significant deficiencies and material weaknesses in the design or
operation of internal
control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize
and report financial information; and
 
 b.    Any fraud,
whether or not material, that involves management or other employees who have a
significant role in the registrant’s internal control over financial
reporting.
  April 15, 2009
                
                /s/ Liu Zhong
      YiLiu Zhong Yi, CEO,
      Presidentand principal executive
      officer